At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7 enrolled
Drug / intervention
Transcranial Magnetic Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TMS for Improving Response Inhibition in Adolescents With OCD
In Brief
A clinical study evaluating Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder. Completed, enrolled 7 participants across 1 site.
Detailed Summary
The study will examine whether inhibition of the pre-supplementary motor area (pSMA) using transcranial magnetic stimulation (TMS) normalizes activity in pSMA-connected circuits, improves response inhibition, and reduces compulsions in adolescents with OCD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive-Compulsive Disorder
CountriesUnited States
CollaboratorsButler Hospital, University of Minnesota
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartApr 2022
Primary CompletionAug 2023
Study CompletionSep 2023
TodayJul 2026
First PostedNov 3, 2021
Enrollment StartApr 1, 2022
Primary CompletionAug 1, 2023
Study CompletionSep 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.7 years ago
Interventions
Transcranial Magnetic Stimulationdevice
All teens will receive active TMS; they will be randomly assigned to receive active TMS at either visit 1 or visit 2 (order counterbalanced)